Kyowa Kirin, Inc.- U.S. · 3 days ago
Director of Pharmacometrics- Clinical Pharmacology
Kyowa Kirin is a fast-growing global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines. The Director of Pharmacometrics will lead a team of Pharmacometricians within the Global Development Organization and Clinical Pharmacology function, focusing on model informed drug development strategies and ensuring high-quality pharmacometrics deliverables.
Pharmaceuticals
Responsibilities
Accountable for pharmacometrics deliverables supporting project teams, ensuring scientific quality, timeliness, and impact; identify and drive opportunities to advance quantitative clinical pharmacology across the organization
Guide pharmacometrics strategy and ensure high-quality preparation of pharmacometric components for scientific reports, regulatory submissions, and responses to health authority inquiries
Provide scientific and technical leadership to pharmacometrics staff, ensuring excellence in modeling approaches and effective communication at all organizational levels
Support clear and impactful communication of pharmacometric and clinical pharmacology results to diverse internal and external audiences
Collaborate with GDO Clinical Pharmacology colleagues and cross-functional partners to improve efficiency, alignment, and innovation across drug development initiatives
Advance Model-Informed Drug Development (MIDD) standards by incorporating best practices from the scientific community to continuously improve workflows, processes, and analytical rigor
Establish and implement workflows, tools, and training programs, leveraging internal and external resources to strengthen pharmacometrics capabilities within GDO Clinical Pharmacology, with particular focus on developing Pharmacometrics Leads
Develop and maintain a network of preferred external pharmacometrics experts to support advanced or specialized analyses as needed
Promote scientific visibility through conference presentations and peer-reviewed publications, ensuring dissemination of insights and research outcomes to the broader scientific community
Qualification
Required
Minimum 10 years of pharmaceutical industry experience gained in pharmacometrics / quantitative clinical pharmacology is required
The understanding and ability to communicate and apply MIDD strategies to drug development
Understanding of pharmacometrics contributions for successful clinical development of small molecules, biologics, and alternative therapies
Experience in the successful use of MIDD to support drug development decision making
Ability to conduct hands-on modeling and simulation using appropriate quantitative tools in a regulated drug development environment, considered expert in field
Experience in the preparation of strategic regulatory documents including reports, summary documents, and response to information requests
Leadership of a team with various backgrounds and skills in pharmacometrics
Experience of developing individuals pharmacometric and communication skills and talents
Proficient in MS Office Suite
Demonstrated proficiency with pharmacometric software tools for non-linear mixed effects modeling, data manipulation, physiologically based pharmacology, and systems pharmacology modeling, such as: Julia/Pumas app, R-studio, NONMEM
Preferred
PhD preferred with specialty training in Pharmacometrics, appropriate MS or PharmD also applicable
Benefits
401K with company match
Discretionary Profit Share
Annual Bonus Program (Sales Bonus for Sales Jobs)
Generous PTO and Holiday Schedule which includes Summer and Winter Shut-Downs, Sick Days and, Volunteer Days
Healthcare Benefits (Medical, Dental, Prescription Drugs and Vision)
HSA & FSA Programs
Well-Being and Work/Life Programs
Life & Disability Insurance
Concierge Services
Long Term Incentive Program (subject to job level and performance)
Pet Insurance
Tuition Assistance
Employee Referral Awards
Company
Kyowa Kirin, Inc.- U.S.
Kyowa Kirin is a global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines.
Funding
Current Stage
Late StageLeadership Team
Recent News
Business Journals
2024-03-08
2024-03-03
Company data provided by crunchbase